周瑞,项昌培,张晶晶,杨洪军
ZHOU Rui,XIANG Chang-pei,ZHANG Jing-jing,YANG Hong-jun

• 1:云南中医药大学中药学院
• 2:中国中医科学院中药研究所
• 3:北京脑科学与类脑研究中心

摘要(Abstract)：

黄连为临床常用的清热解毒药,始载于《神农本草经》,列为上品。传统中医将其用于湿热痞满、呕吐吞酸、泻痢、痈疽疮毒、心火亢盛等。目前从黄连中分离鉴定出的化学成分共133种,按照结构类型的差异简单将其分为生物碱类(44种)、木脂素类(32种)、黄酮类(9种)、苯丙酸及其衍生物类(26种)和其他化合物(22种)。现代研究表明,小檗碱是黄连最重要的活性成分之一,具有抗菌、抗病毒、抗胃溃疡等药理作用,还在降糖、降血脂、抗肿瘤以及抗心脑血管疾病方面发挥着重要的作用。该文对黄连化学成分进行总结,并对其主要活性成分小檗碱药理作用进行综述,以期为黄连及小檗碱的深入研究、开发和临床应用提供参考。
Coptidis Rhizoma was a commonly used antipyretic and dampening drug in clinic, which was first recorded in the Shennong′s Herbal Classic of Materia Medica and which was listed as one of the highest grade herb in traditional Chinese medicine. Traditionally, Coptidis Rhizoma was used to treat dampness with distention and fullness, vomiting with acid regurgitation, acne, heartbum, etc. At present, a total of 133 chemical components have been isolated and identified from Coptidis Rhizoma, which can be divided into alkaloids(44 species), lignans(32 species), flavonoids(9 species), phenylpropionic acid and its derivatives(26 species) and other compounds(22 species) according to the differences in structure types. Modern studies have shown that berberine is one of the most important active composition of Coptidis Rhizoma, which not only has an effect on the antibacterial, antiviral and anti-gastric ulcer, but also plays a vital role in reducing blood sugar, lowering blood fat, anti-tumor and treating cardiovascular and cerebrovascular diseases. The chemical constituents of Coptidis Rhizoma and pharmacological effects of berberine were reviewed in this study, which was expected to provide references for the further research, development of and clinical application of Coptidis Rhizoma and berberine.

关键词(KeyWords)： 黄连;化学成分;药理作用;小檗碱
Coptidis Rhizoma;chemical compositions;pharmacological effects;berberine

Abstract:

Keywords:

基金项目(Foundation): 国家重点研发计划项目(2017YFC1702605);; 国家自然科学基金项目(81974550);; 中央公益性研究机构基础研究经费项目(ZZ13-YQ-046)

作者(Author): 周瑞,项昌培,张晶晶,杨洪军
ZHOU Rui,XIANG Chang-pei,ZHANG Jing-jing,YANG Hong-jun

参考文献(References)：

• [1] 国家药典委员会.中华人民共和国药典.一部[S].北京:中国医药科技出版社,2015:303.
• [2] 王薇,张庆文,叶文才,等.黄连中的异喹啉类生物碱[J].中国天然药物,2007,5(5):348.
• [3] 匡艳辉,朱晶晶,王智民,等.黄连属药用植物化学成分和质量控制的研究进展[J].中国药学杂志,2008,43(15):1121.
• [4] COOPER S F,MOCKLE J A,BELIVEAU J.Alkaloids of Coptis groenlandica[J].Planta Med,1970,19(1):23.
• [5] NOGUCHI M,KUBO M,HAYASHI T,et al.Studies on the pharmaceutical quality evaluation of crude drug preparations used in orient medicine "Kampoo".Ⅲ.Precipitation reaction of glycyrrhizin with alkaloids or alkaloidal crude drugs in aqueous solution[J].Chem Pharm Bull,1978,26(12):3652.
• [6] 张冬梅.黄连生物碱成分的HPLC-DAD-MS分析[J].健康之路,2016(6):254.
• [7] 董芹,王伽伯,张定堃,等.基于效应成分当量的黄连饮片调剂一致性研究[J].中国中药杂志,2015,40(20):3981.
• [8] 李志峰,王琦,冯育林,等.黄连的化学成分研究[J].中草药,2012,43(7):1273.
• [9] WANG L,ZHANG S Y,CHEN L,et al.New enantiomeric isoquinoline alkaloids from Coptis chinensis[J].Phytochem Lett,2014,7:89.
• [10] CHEN J,WANG F,LIU J,et al.Analysis of alkaloids in Coptis chinensis Franch by accelerated solvent extraction combined with ultra performance liquid chromatographic analysis with photodiode array and tandem mass spectrometry detections[J].Anal Chim Acta,2008,613(2):184.
• [11] 刘芳,宋丽华,武勇.不同贮藏期黄连的化学成分分析[J].长治医学院学报,2017,31(2):101.
• [12] 刘芳,张浩,青琳森,等.不同生长条件下峨眉产黄连个体生物量及生物碱类成分含量的比较[J].中国实验方剂学杂志,2015,21(18):21.
• [13] 布赫,王立乾,唐振球,等.UPLC-ESI-Q-TOF-MSE快速鉴定黄连中生物碱类成分[J].化学工程师,2018,32(2):21.
• [14] MIZUNO M,KOJIMA H,IINUMA M,et al.Coumarin derivatives in Coptis trifolia[J].Ann Proc Gifu Coll Pharm,1992,31(2):717.
• [15] 吴晓青,时晓媞,蒋合众,等.川黄连多指标成分定量及特征图谱建立研究[J].世界科学技术——中医药现代化,2019,21(8):1642.
• [16] YANG T C,CHAO H F,SHI L S,et al.Alkaloids from Coptis chinensis root promote glucose uptake in C2C12 myotubes[J].Fitoterapia,2014,93:239.
• [17] ZHAO M,XIAN Y F,IP S P,et al.A new and weakly antispasmodic protoberberine alkaloid from Rhizoma Coptidis[J].Phytother Res,2010,24(9):1414.
• [18] MA B,ZHU L,ZANG X,et al.Coptis chinensis inflorescence and its main alkaloids protect against ultraviolet-B-induced oxidative damage[J].J Func Foods,2013,5(4):1665.
• [19] MIZUNO M,KOJIMA H,TANAKA T,et al.Phenolic consti-tuents from seeds of Coptis japonica var.dissecta[J].Phytochem,1987,26(7):2071.
• [20] 马红梅,陈刚,裴月湖.黄连化学成分的分离鉴定及其药理活性[J].沈阳药科大学学报,2013,30(10):759.
• [21] 李雪改,杨立国,陈丽霞,等.黄连水提液化学成分的分离与鉴定[J].沈阳药科大学学报,2012,29(3):193.
• [22] LI Z F,WANG Q,CHEN G,et al.A new pyrrolidine derivative from the rhizome of Coptis chinensis[J].Chem Nat Compd,2013,49(3):493.
• [23] 陈亮,王磊,张庆文,等.黄连非生物碱类化学成分研究[J].中国中药杂志,2012,37(9):1241.
• [24] LI Z Q,ZUO D Y,QIE X D,et al.Berberine acutely inhibits the digestion of maltose in the intestine[J].J Ethnopharmacol,2012,142(2):474.
• [25] YOSHIKAWA K,HIROSHI KINOSHITA A,ARIHARA S.Woorenol,a novel sesquineolignan with a unique spiro skeleton,from the rhizomes of Coptis japonica var.dissecta[J].J Nat Prod,1997,60(5):511.
• [26] WANG L,ZHANG S Y,CHEN L,et al.New enantiomeric isoquinoline alkaloids from Coptis chinensis[J].Phytochem Lett,2014,7(1):89.
• [27] 陈瑞,吴云,田维毅.黄连化学成分及其影响相关代谢途径的研究进展[J].湖南中医杂志,2016,32(4):190.
• [28] 赵薪苑,陈婧,方建国,等.中药和天然药物中黄酮抗病毒活性及其机制研究进展[J].医药导报,2018,37(4):410.
• [29] 孟凡成,王磊,张健,等.云南黄连中非生物碱类化学成分的研究[J].中国药科大学学报,2013,44(4):307.
• [30] YOSHIKAWA K,HIROSHI KINOSHITA A,KAN Y,et al.Neolignans and phenylpropanoids from the rhizomes of Coptis japonica var.dissecta[J].Chem Pharm Bull,1995,43(4):578.
• [31] YOSHIKAWA K,HIROSHI KINOSHITA A,ARIHARA S,et al.Non-basic component of Coptis Rhizoma.Ⅱ.Four new hemiterpenoid glucosides,two new phenylpropanoid glucosides and a new flavonoid glycoside from Coptis japonica var.dissecta[J].Nat Med,1997,51:244.
• [32] HIRANO H,TOKUHIRA T,YOKOI T,et al.Isolation of free radical scavenger from Coptidis Rhizoma[J].Nat Med,1997,51:539.
• [33] 陈国超,李小莉,陈广.黄连中木脂素类化合物的分离鉴定及其对蛋白酪氨酸磷酸酶1B的抑制活性[J].中国药房,2016,27(16):2197.
• [34] FUJIWARA H,NONAKA G,YAGI A,et al.Studies on the components of the leaves of Coptis japonica Makino.Ⅰ.The structures of coptiside Ⅰ and Ⅱ[J].Chem Pharm Bull,1976,24(3):407.
• [35] 李淑娇,王宇卿.HPLC-ABTS-DAD-Q-TOF/MS在线筛选黄连抗氧化活性物质[J].中国中药杂志,2018,42(12):2570.
• [36] YAHARA S,SATOSHIRO M,NISHIOKA I,et al.Isolation and characterization of phenolic compounds from Coptidis Rhizoma[J].Chem Pharm Bull,1985,33(2):527.
• [37] 魏雅蕾,昶国平,李广雷,等.黄连的化学成分、药理作用及作用机制研究进展[C].北京:中华中医药学会中药化学分会第九届学术年会,2014.
• [38] MA B L,MA Y M.Pharmacokinetic properties,potential herb-drug interactions and acute toxicity of oral Rhizoma Coptidis alkaloids[J].Expert Opin Drug Metab Toxicol,2013,9(1):51.
• [39] 王维琪.黄连有效成分的药理研究与进展[J].中医临床研究,2016,8(26):147.
• [40] WANG J,WANG L,LOU G H,et al.Coptidis Rhizoma:a comprehensive review of its traditional uses,botany,phytochemistry,pharmacology and toxicology[J].Pharm Biol,2019,57(1):193.
• [41] MENG F C,WU Z F,YIN Z Q,et al.Coptidis Rhizoma and its main bioactive components:recent advances in chemical investigation,quality evaluation and pharmacological activity[J].Chin Med,2018,13:13.
• [42] GBD 2013 Mortality and Causes of Death Collaborators.Global,regional,and national age-sex specific all-cause and cause-specific mortality for 240 causes of death,1990—2013:a syste-matic analysis for the Global Burden of Disease Study 2013[J].Lancet,2015,385(9963):117.
• [43] THOMAS H,DIAMOND J,VIECO A,et al.Global atlas of cardiovascular disease 2000—2016:the path to prevention and control[J].Glob Heart,2018,13(3):143.
• [44] TAN H L,CHAN K G,PUSPARAJAH P,et al.Rhizoma Coptidis:a potential cardiovascular protective agent[J].Front Pharmacol,2016,7:362.
• [45] 杜见益.黄连素治疗心律失常108例的疗效观察[J].海南医学,2006,17(7):86.
• [46] 王春艳,王桂茹,李晶,等.盐酸小檗碱抗实验性心律失常的研究[J].中国老年学杂志,2009,29(6):651.
• [47] 房辉,汪晖,李泱.小檗碱对急性缺血心肌的保护作用[J].咸宁学院学报:医学版,2004,18(5):308.
• [48] WANG Y X,ZHENG Y M,ZHOU X B.Inhibitory effects of berberine on ATP-sensitive K+channels in cardiac myocytes[J].Eur J Pharmacol,1996,316:307.
• [49] 杨静,王巧云.小檗碱和利多卡因抗实验性心律失常作用[J].中国现代药物应用,2010,4(3):14.
• [50] 司晓晨.黄连素片对钙离子通道的拮抗作用[J].南京中医药大学学报,1996,12(6):20.
• [51] WANG L H,YU C H,FU Y,et al.Berberine elicits anti-arrhythmic effects via IK1/Kir 2.1 in the rat type 2 diabetic myocardial infarction model[J].Phytother Res,2011,25(1):33.
• [52] 于锋,林木森,张伟东.盐酸小檗碱对甲状腺素性豚鼠心肌病心肌细胞中IKr,IKs和IK1的抑制作用[J].中国药科大学学报,2009,40(3):244.
• [53] 李永民,陈晓春,刘华,等.人参总皂苷合黄连小檗碱对慢性心衰大鼠血浆BNP、心肌细胞内钙离子浓度的影响[J].中国中药杂志,2009,34(3):324.
• [54] 张恩浩,钟国强,黎庆捷,等.黄连素抗慢性心力衰竭机制的动物实验研究[J].局解手术学杂志,2012,21(3):258.
• [55] ZENG X H,ZENG X J,LI Y Y.Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy[J].Am J Cardiol,2003,92(2):173.
• [56] 张利生.小檗碱临床用途[J].中国药物与临床,2004,4(1):78.
• [57] KO W H,YAO X Q,LAU C W,et al.Vasorelaxant and antiproliferative effects of berberine[J].Eur J Pharmacol,2000,399:187.
• [58] 李运伦.自发性高血压大鼠左室心肌纤维化与黄连清降合剂的干预效应[J].中国组织工程研究,2007,11(47):9466.
• [59] LIU L,LIU J,HUANG Z,et al.Berberine improves endothelial function by inhibiting endoplasmic reticulum stress in the carotid arteries of spontaneously hypertensive rats[J].Biochem Biophys Res Commun,2015,458(4):796.
• [60] GUO Z,SUN H,ZHANG H,et al.Anti-hypertensive and renoprotective effects of berberine in spontaneously hypertensive rats[J].Clin Exp Hypertens,2015,37(4):332.
• [61] 冯栓林,刘顺兴,冯清燕,等.盐酸小檗碱与小剂量阿司匹林防治缺血性中风的临床与实验对比研究(论著摘要)[J].中国神经免疫学和神经病学杂志,1996,3(4):224.
• [62] MADRI J A.Modeling the neurovascular niche:implications for recovery from CNS injury[J].J Physiol Pharmacol,2009,60:95.
• [63] AHMED T,GILANI A U,ABDOLLAHI M,et al.Berberine and neurodegeneration:a review of literature[J].Pharmacol Rep,2015,67(5):970.
• [64] HU Y Y,ZHENG M H,CHENG G,et al.Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells[J].BMC Cancer,2011,11(1):82.
• [65] ZHANG J,YANG J Q,HE B C,et al.Berberine and total base from rhizoma Coptis chinensis attenuate brain injury in an aluminum-induced rat model of neurodegenerative disease[J].Saudi Med J,2009,30(6):760.
• [66] 刘北忠,张静,杨俊卿,等.小檗碱对铝过负荷致小鼠慢性脑损伤的保护作用及机制[J].中草药,2008,39(9):1351.
• [67] PANG Y N,LIANG Y W,WANG Y G,et al.Effect of berbe-rine against cerebral ischemia and reperfusion involving in the methylation of PPARγ promoter [J].J Chin Pharm Sci,2018,27(3) :170.
• [68] YANG J,YAN H,LI S,et al.Berberine ameliorates MCAO induced cerebral ischemia/reperfusion injury via activation of the BDNF-TrkB-PI3K/Akt signaling pathway[J].Neurochem Res,2018,43(7):1.
• [69] ZHOU X Q,ZENG X N,KONG H,et al.Neuroprotective effects of berberine on stroke models in vitro and in vivo[J].Neurosci Lett,2008,447(1):31.
• [70] ZHANG Q,QIAN Z,PAN L,et al.Hypoxia-inducible factor 1 mediates the anti-apoptosis of berberine in neurons during hypoxia/ischemia[J].Acta Physiol Hung,2012,99(3):311.
• [71] 曹洁,张颖冬,高擎,等.小檗碱对局灶性脑缺血大鼠半暗带炎症反应及NF-κB p65、caspase-1表达的影响[C].厦门:中华医学会第十七次全国神经病学学术会议,2014:247.
• [72] KONG W J,HAO Z,SONG D Q,et al.Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression[J].Metab Clin Exp,2009,58(1):109.
• [73] YI P,LU F E,XU L J,et al.Berberine reverses free-fatty-acid-induced insulin resistance in 3T3-L1 adipocytes through targeting IKKβ[J].World J Gastroenterol,2008,14(6):876.
• [74] COK A,PLAISIER C,SALIE M J,et al.Berberine acutely activates the glucose transport activity of GLUT1[J].Biochimie,2011,93(7):1187.
• [75] KIM S H,SHIN E J,KIM E D,et al.Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes[J].Biol Pharm Bull,2007,30(11):2120.
• [76] 王增四.小檗碱改善2型糖尿病大鼠胰岛素抵抗与PI-3K、GLUT4蛋白相关性的研究[J].中国药理学通报,2008,24(8):1007.
• [77] MA X,EGAWA T,KIMURA H,et al.Berberine-induced activation of 5′-adenosine monophosphate-activated protein kinase and glucose transport in rat skeletal muscles[J].Metab Clin Exp,2010,59(11):1619.
• [78] 潘国宇,王广基,孙建国,等.小檗碱对葡萄糖吸收的抑制作用[J].药学学报,2003,38(12):911.
• [79] 汪群红,何贤君,胡敏,等.小檗碱对Ⅱ型糖尿病大鼠降血糖作用的药效学研究[J].中华中医药学刊,2016,34(10):2531.
• [80] YIN J,HU R,CHEN M,et al.Effects of berberine on glucose metabolism in vitro[J].Metab Clin Exp,2002,51(11):1439.
• [81] JIN Y,LIU S,MA Q,et al.Berberine enhances the AMPK activation and autophagy and mitigates high glucose-induced apoptosis of mouse podocytes[J].Eur J Pharmacol,2016,794:106.
• [82] ZHANG Q,XIAO X,LI M,et al.Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine[J].Bmc Complement Altern Med,2014,14(1):188.
• [83] 韩莉,杨钦河,张玉佩,等.小檗碱对高脂饮食诱导非酒精性脂肪性肝病大鼠肝细胞脂质沉积的干预作用[J].中国中西医结合杂志,2015,35(3):314.
• [84] HUANG C,ZHANG Y,GONG Z,et al.Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway[J].Biochem Biophys Res Commun,2006,348(2):571.
• [85] CAO S,ZHOU Y,XU P,et al.Berberine metabolites exhibit triglyceride-lowering effects via activation of AMP-activated protein kinase in HepG2 cells[J].J Ethnopharmacol,2013,149(2):576.
• [86] KATONA B W,LIU Y,MA A,et al.EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells[J].Cancer Biol Ther,2014,15(12):1677.
• [87] HUANG Z H,ZHENG H F,WANG W L,et al.Berberine targets epidermal growth factor receptor signaling to suppress prostate cancer proliferation in vitro[J].Mol Med Rep,2015,11(3):2125.
• [88] KALAIARASI A,ANUSHA C,SANKAR R,et al.Plant isoquinoline alkaloid berberine exhibits chromatin remodeling by modulation of histone deacetylase to induce growth arrest and apoptosis in the A549 cell line[J].J Agric Food Chem,2016,64(50):9542.
• [89] WANG J,KANG M,WEN Q,et al.Berberine sensitizes nasopharyngeal carcinoma cells to radiation through inhibition of Sp1 and EMT[J].Oncol Rep,2017,37(4):2425.
• [90] JIN H,JIN X,CAO B,et al.Berberine affects osteosarcoma via downregulating the caspase-1/IL-1β signaling axis[J].Oncol Rep,2017,37(2):729.
• [91] SU Y H,TANG W C,CHENG Y W,et al.Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer[J].Biochim Biophys Acta,2015,1853(10):2261.
• [92] MISTRY B M,KEUM Y S,PANDURANGAN M,et al.Synthesis and evaluation of antioxidant and cytotoxicity of the N-mannich base of berberine bearing benzothiazole moieties[J].Anticancer Agents Med Chem,2017,17(12):1652.
• [93] LU W,DU S,WANG J.Berberine inhibits the proliferation of prostate cancer cells and induces G0/G or G/M phase arrest at different concentrations[J].Mol Med Rep,2015,11(5):3920.
• [94] AGNARELLI A,NATALI M,GARCIA-GIL M,et al.Cell-specific pattern of berberine pleiotropic effects on different human cell lines[J].Sci Rep,2018,8(1):10599.
• [95] LI H,GUO L,JIE S,et al.Berberine inhibits SDF-1-induced AML cells and leukemic stem cells migration via regulation of SDF-1 level in bone marrow stromal cells[J].Biomed Pharmacother,2008,62(9):573.
• [96] WU Y Q,CHEN X S,CHAI J B.The involvement of the CD40-CD40L pathway in activated platelet-induced vhanges in HUVEC COX-2 and PPARα expression[J].Inflammation,2012,35(3):1184.
• [97] CAI H L,DONG F W,HANG D,et al.Berberine hydrochloride impact on physiological processes and modulation of twist levels in nasopharyngeal carcinoma CNE-1 cells[J].Asian Pac J Cancer Prev,2014,15(4):1851.
• [98] LIU L,CHEN L,JIANG C,et al.Berberine inhibits the LPS induced proliferation and inflammatory response of stromal cells of adenomyosis tissues mediated by the LPS/TLR4 signaling pathway[J].Exp Ther Med,2017,14(6):6125.
• [99] HAMSA T P,KUTTAN G.Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1,VEGF,and proinflammatory mediators[J].Drug Chem Toxicol,2012,35(1):57.
• [100] HO Y T,YANG J S,LI T C,et al.Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK,IKK,NF-κB,u-PA and MMP-2 and-9[J].Cancer Lett,2009,279(2):155.
• [101] KIM S,HAN J,LEE S K,et al.Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells[J].J Surg Res,2012,176(1):e21.
• [102] KUO H P,CHUANG T C,TSAI S C,et al.Berberine,an isoquinoline alkaloid,inhibits the metastatic potential of breast cancer cells via Akt pathway modulation[J].J Agri Food Chem,2012,60(38):9649.
• [103] LIU B,WANG G,YANG J,et al.Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes[J].PLoS ONE,2011,6(6):e21416.
• [104] NAVEEN C R,GAIKWAD S,AGRAWAL-RAJPUT R.Berbe-rine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells[J].Phytomedicine,2016,23(7):736.
• [105] MISHAN M A,AHMADIANKIA N,MATIN M M,et al.Role of berberine on molecular markers involved in migration of esophageal cancer cells[J].Cell Mol Biol,2015,61(8):37.
• [106] HAMSA T P,KUTTAN G.Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1,VEGF,and proinflammatory mediators[J].Drug Chem Toxicol,2012,35(1):57.
• [107] 娄金丽,邱全瑛,郝钰,等.小檗碱抗肿瘤新生血管形成作用机制的研究[J].中国免疫学杂志,2006,22(3):235.
• [108] DEROSA G,MAFFIOLI P,CICERO A F.Berberine on metabolic and cardiovascular risk factors:an analysis from preclinical evidences to clinical trials[J].Expert Opin Biol Ther,2012,12(8):1113.
• [109] 田金凤.玄参和黄连的化学成分分离及其生物活性研究[D].重庆:西南大学,2013.
• [110] ZHANG Q,PIAO X L,PIAO X S,et al.Preventive effect of Coptis chinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides[J].Food Chem Toxicol,2011,49(1):61.
• [111] LI H M,WANG Y Y,WANG H D,et al.Berberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms[J].Acta Pharmacol Sin,2011,32(11):1364.
• [112] GU L L,LI N,GONG J F,et al.Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia[J].J Infect Dis,2011,203(11):1602.
• [113] ALZAMORA R,O′MAHONY F,KO W H,et al.Berberine reduces cAMP-induced chloride secretion in T84 human colonic carcinoma cells through inhibition of basolateral KCNQ1 channels[J].Front Physiol,2011,2:33.
• [114] ZHANG Y,WANG X,SHA S,et al.Berberine increases the expression of NHE3 and AQP4 in sennoside A-induced diarrhoea model[J].Fitoterapia,2012,83(6):1014.
• [115] HAYASHI K,MINODA K,NAGAOKA Y,et al.Antiviral activity of berberine and related compounds against human cytomegalovirus[J].Bioorg Med Chem Lett,2007,17(6):1562.
• [116] SHIN H B,CHOI M S,YI C M,et al.Inhibition of respiratory syncytial virus replication and virus-induced p38 kinase activity by berberine[J].Int Immunopharmacol,2015,27(1):65.
• [117] 孟菁菁.小檗碱对Epstein-Barr病毒DNA复制的抑制作用[D].长沙:中南大学,2009.
• [118] CECIL C E,DAVIS J M,CECH N B,et al.Inhibition of H1N1 influenza A virus growth and induction of inflammatory mediators by the isoquinoline alkaloid berberine and extracts of goldenseal (Hydrastis canadensis)[J].Int Immunopharmacol,2011,11(11):1706.
• [119] 赵志刚,徐小军,庄洁,等.盐酸小檗碱、鱼腥草素钠和大蒜素的体外抗菌活性[J].中国临床药理学杂志,2005,21(2):119.
• [120] KRISHNAN P,BASTOW K F.The 9-position in berberine analogs is an important determinant of DNA topoisomerase Ⅱ inhibition[J].Anticancer Drug Des,2000,15(4):255.
• [121] LI T K,BATHORY E,LAVOIE E J,et al.Human topoisome-rase I poisoning by protoberberines:potential roles for both drug-DNA and drug-enzyme interactions[J].Biochemistry,2000,39(24):7107.
• [122] WANG X,QIU S,YAO X,et al.Berberine inhibits Staphylococcus epidermidis adhesion and biofilm formation on the surface of titanium alloy[J].J Orthop Res,2010,27(11):1487.
• [123] WANG X,YAO X,ZHU Z,et al.Effect of berberine on Staphy-lococcus epidermidis biofilm formation[J].Int J Antimicrob Agents,2009,34(1):60.
• [124] 任弟娟.小檗碱抗幽门螺杆菌持留菌机制的研究[D].兰州:兰州大学,2018.
• [125] KANG S,LI Z,YIN Z,et al.The antibacterial mechanism of berberine against Actinobacillus pleuropneumoniae[J].Nat Prod Res,2015,29(23):2203.
• [126] PENG L,KANG S,YIN Z,et al.Antibacterial activity and mechanism of berberine against Streptococcus agalactiae[J].Int J Clin Exp Pathol,2015,8(5):5217.
• [127] LIU Y X,XIAO C L,WANG Y X,et al.Synthesis,structure-activity relationship and in vitro anti-mycobacterial evaluation of 13-n-octylberberine derivatives[J].Eur J Med Chem,2012,52:151.
• [128] RABBANI G H,BUTLER T,KNIGHT J,et al.Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae[J].J Infect Dis,1987,155(5):979.
• [129] LEE B,SUR B,YEOM M,et al.Effect of berberine on depression-and anxiety-like behaviors and activation of the noradrenergic system induced by development of morphine dependence in rats[J].Korean J Physiol Pharmacol,2012,16(6):379.
• [130] KULKARNI S K,DHIR A.On the mechanism of antidepressant-like action of berberine chloride[J].Eur J Pharmacol,2008,589:163.
• [131] KULKARNI S K,DHIR A.Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride[J].Eur J Pharmacol,2007,569:77.